capecitabine has been researched along with Anogenital Type Verrucous Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ben Kridis, W; Boudawara, T; Charfi, S; Daoud, J; Khanfir, A; Mzali, R; Toumi, N; Werda, I | 1 |
1 review(s) available for capecitabine and Anogenital Type Verrucous Carcinoma
| Article | Year |
|---|---|
Buschke - Lowenstein anal tumor: an ambiguous entity.
Topics: Animals; Antimetabolites, Antineoplastic; Anus Neoplasms; Buschke-Lowenstein Tumor; Capecitabine; Cisplatin; Humans; Male; Malpighian Tubules; Middle Aged; Papillomavirus Infections | 2019 |